Enhanced gene delivery mediated by low molecular weight chitosan/DNA complexes: effect of pH and serum.
This study was designed to systematically evaluate the influence of pH and serum on the transfection process of chitosan-DNA complexes, with the objective of maximizing their efficiency. The hydrodynamic diameter of the complexes, measured by dynamic light scattering (DLS), was found to increase with salt and pH from 243 nm in water to 1244 nm in PBS at pH 7.4 and aggregation in presence of 10% serum. The cellular uptake of complexes into HEK 293 cells assessed by flow cytometry and confocal fluorescent imaging was found to increase at lower pH and serum. Based on these data, new methodology were tested and high levels of transfection (>40%) were achieved when transfection was initiated at pH 6.5 with 10% serum for 8-24 h to maximize uptake and then the media was changed to pH 7.4 with 10% serum for an additional 24-40 h period. Cytotoxicity of chitosan/DNA complexes was also considerably lower than Lipofectamine. Our study demonstrates that the evaluation of the influence of important parameters in the methodology of transfection enables the understanding of crucial physicochemical and biological mechanisms which allows for the design of methodologies maximising transgene expression.
Nimesh
Surendra
S
Department of Chemical Engineering, Institute of Biomedical Engineering, Ecole Polytechnique of Montreal, P.O. Box 6079, Station Centre-Ville, Montreal, QC, H3C 3A7, Canada.
Thibault
Marc M
MM
Lavertu
Marc
M
Buschmann
Michael D
MD
D000818:Animals; D002417:Cattle; D048271:Chitosan; D004247:DNA / Q000008:administration & dosage* / Q000378:metabolism*; D018014:Gene Transfer Techniques; D057809:HEK293 Cells; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008156:Luciferases / Q000032:analysis; D014162:Transfection / Q000379:methods*
D004247:DNA; D048271:Chitosan; D008156:Luciferases
Pharm Res. 2003 Nov;20(11):1812-9
14661926
J Control Release. 2006 May 15;112(2):223-8
16556468
Biotechnol Bioeng. 2000 Mar 5;67(5):585-97
10649233
Proc Natl Acad Sci U S A. 1974 Apr;71(4):1286-90
4524638
Biomacromolecules. 2007 Oct;8(10):3224-34
17850110
Biomacromolecules. 2009 Jun 8;10(6):1490-9
19419142
Eur J Pharm Biopharm. 2006 Jan;62(1):17-25
16257520
Biomaterials. 2006 Mar;27(9):2060-5
16202449
Eur J Pharm Biopharm. 2004 Jan;57(1):1-8
14729076
Biomaterials. 2003 Mar;24(7):1121-31
12527253
Sci Am. 1997 Jun;276(6):102-6
9163942
Biomaterials. 2009 Mar;30(9):1797-808
19110309
J Immunol Methods. 1997 May 26;204(2):205-8
9212838
Biotechnol Prog. 1991 Nov-Dec;7(6):481-94
1367750
Adv Drug Deliv Rev. 2003 Apr 25;55(4):483-99
12706047
Biomaterials. 2006 Sep;27(27):4815-24
16725196
Adv Drug Deliv Rev. 2001 Nov 5;52(2):145-50
11718938
Bioconjug Chem. 2006 Mar-Apr;17(2):309-16
16536460
Mol Cell Biol. 1987 Feb;7(2):725-37
3821727
Pharm Res. 1997 Jul;14(7):923-9
9244151
Science. 1989 Nov 3;246(4930):603-8
2683075
Int J Pharm. 2006 Jun 6;315(1-2):44-51
16563672
Gene Ther. 2009 Sep;16(9):1097-110
19440230
Int J Pharm. 1999 Feb 15;178(2):231-43
10205643
Int J Pharm. 2003 Feb 18;252(1-2):263-6
12550802
Biotechnol Bioeng. 1988 Oct 5;32(8):947-65
18587813
Gene Ther. 1996 Mar;3(3):269-73
8646559
Pharm Res. 1998 Sep;15(9):1332-9
9755882
Curr Opin Biotechnol. 2002 Apr;13(2):128-31
11950563
J Control Release. 1998 Dec 4;56(1-3):259-72
9801449
J Control Release. 2005 Sep 2;106(3):391-406
15967533
Biomaterials. 2001 Aug;22(15):2075-80
11432586
J Drug Target. 2004 Jun;12(5):281-8
15512779
J Immunol Methods. 1998 Apr 15;213(2):157-67
9692848
J Control Release. 2001 Feb 23;70(3):399-421
11182210
Int J Pharm. 2002 Oct 1;245(1-2):83-91
12270245